Patient Treated With Lithium, With Bipolar or Schizo-affective Disorder, Hospitalized in a Psychiatric Ward
Conditions
Keywords
Lithium, observance, security, Lithium Knowledge Test
Brief summary
Lithium is a drug used to treat several psychiatric illnesses. This medication requires particular vigilance because it has a narrow therapeutic margin: the dose necessary to obtain an effective treatment is close to the toxic dose. The blood dosage of the drug and the patient's knowledge of the drug are necessary to optimize and secure the drug intake. The objective of this observational study is to confirm that the score obtained by the LKT lithium knowledge self-questionnaire translated into French is representative of the knowledge of patients treated with lithium. Participants will be asked to complete this questionnaire twice, and the scores obtained will be compared to the blood lithium level to see if a good score is associated with an effective blood lithium concentration.
Interventions
None listed
Sponsors
University Hospital, Lille
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient hospitalized in a psychiatric ward or in an EPSM for more than 10 consecutive days * Patient treated with IR or ER lithium LI * Patient over 18 years of * Patient on a fixed dosage of lithium for more than 5 days prior to blood sampling for lithiaemia testing * Obtain patient's non-opposition
Exclusion criteria
* Clinically unstable patient or patient with a cognitive disorder that makes it impossible to perform interview and/or completion of the LKT self-questionnaire * Patients under guardianship or trusteeship * Illiterate patients * Patient with a therapeutic target concentration different from general recommendations (e.g. elderly subject) * Patient receiving a pharmaceutical interview or any other interview between the completion of the 1 and 2nd questionnaires, likely to modify the LKT score.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of the factorial validity of the score from the first completed LKT self-questionnaire | 2 yaers | Baseline: percentage of inertia explained by the first component of the principal component analysis Maximum time to obtain scores for 300 self-questionnaires: 2 years |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of the internal consistency of the LKT score: is acceptable if Cronbach's alpha is greater than 0.7 | 2 yaers | Baseline after data collection: percentage of inertia explained by the first component of the principal component analysis Maximum time to obtain scores for 300 self-questionnaires: 2 years |
| External validity of the LKT self-questionnaire by measuring the correlation between the lithiaemia assay at D0 and the score obtained on the self-questionnaire at D0. | 2 yaers | Baseline after data collection: percentage of inertia explained by the first component of the principal component analysis Maximum time to obtain scores for 300 self-questionnaires: 2 years |
| Evaluation of the test/retest reliability of the LKT self-questionnaire score measured at D0 and D4. | 2 years | Baseline and 4 days after data collection Maximum time to obtain scores for 300 self-questionnaires: 2 years |
| Comparison of lithiaemia at D0 between patients with good knowledge (i.e. a LKT self-questionnaire score at D0 > 6) and those with poor knowledge of treatment | 2 years | Baseline and 4 days after data collection Maximum time to obtain scores for 300 self-questionnaires: 2 years |
| Search for factors associated with the LKT self-questionnaire score at J0. | 2 years | Baseline and 4 days after data collection Maximum time to obtain scores for 300 self-questionnaires: 2 years |
Countries
France
Outcome results
None listed